J&J Appeals Court Decision On Stent Dispute With Boston Sci

Date : 04/16/2012 @ 6:15PM
Source : Dow Jones News
Stock : Boston Scientific Corp. (BSX)
Quote : 24.86  -0.16 (-0.64%) @ 3:59PM

J&J Appeals Court Decision On Stent Dispute With Boston Sci

Johnson & Johnson (NYSE:JNJ)
Historical Stock Chart

5 Years : From Apr 2012 to Apr 2017

Click Here for more Johnson & Johnson Charts.

Johnson & Johnson's (JNJ) Cordis unit last week appealed an earlier court decision that it must pay Boston Scientific more than $40 million over a patent dispute involving stents, according to court filings.

A jury had awarded Boston Scientific about $20 million; last month, U.S. Distict Court Judge Sue Robinson wrote that the company should get twice as much, citing "clear and convincing evidence that Cordis's conduct is sufficiently culpable to justify enhancing damages."

Boston Scientific filed a patent infringement lawsuit against Cordis with a U.S. District Court in Minnesota in 2009. The case was later transferred to Delaware.

The dispute marked one in a series of battles over stent patents between the two companies. Boston Scientific declined to comment. J&J didn't immediately respond to requests for comment.

J&J shares fell a fraction to $63.96 in after-hours trading; Boston Scientific is up a fraction to $5.52.

Bloomberg reported the ruling earlier.

-By Anjali Athavaley, Dow Jones Newswires; 212-416-4912; anjali.athavaley@dowjones.com




Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.